Literature DB >> 15747121

[Cystoid macular edema in uveitis].

S R Thurau1.   

Abstract

Cystoid macular edema (CME) is the most frequent cause of visual deterioration in uveitis patients. Intraocular inflammation disturbs the blood-retina barrier and leads to retinal edema. The basis of successful treatment is the anti-inflammatory and immunosuppressive therapy of uveitis. Restoration of the blood-retina barrier is mediated by corticosteroids and nonsteroidal anti-inflammatory agents. Resorption of extracellular fluid is improved by systemic carboanhydrase inhibitors. Despite aggressive therapy loss of visual acuity is frequent. Therefore, early diagnosis of CME and initiation of treatment, even if visual acuity is not yet impeded, is mandatory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15747121     DOI: 10.1007/s00347-005-1183-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.

Authors:  A Martidis; J S Duker; C A Puliafito
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

Review 3.  Medical treatment of cystoid macular edema.

Authors:  Aniki Rothova
Journal:  Ocul Immunol Inflamm       Date:  2002-12       Impact factor: 3.070

4.  A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications.

Authors:  A B Thach; P U Dugel; R J Flindall; J O Sipperley; S R Sneed
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

5.  Medical treatment of macular edema in patients with uveitis.

Authors:  B Rojas; P Zafirakis; W Christen; N N Markomichelakis; C S Foster
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

Review 6.  The pathogenesis and clinical presentation of macular edema in inflammatory diseases.

Authors:  Y Guex-Crosier
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

7.  Causes and frequency of blindness in patients with intraocular inflammatory disease.

Authors:  A Rothova; M S Suttorp-van Schulten; W Frits Treffers; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

8.  Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.

Authors:  Marisol R Castro; David Lutz; Jeffrey L Edelman
Journal:  Exp Eye Res       Date:  2004-08       Impact factor: 3.467

Review 9.  Prostaglandins and cystoid macular edema.

Authors:  Kensaku Miyake; Nobuhiro Ibaraki
Journal:  Surv Ophthalmol       Date:  2002-08       Impact factor: 6.048

10.  Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.

Authors:  Nikos N Markomichelakis; Ioannis Halkiadakis; Eugenia Pantelia; Vasilios Peponis; Andreas Patelis; Panagiotis Theodossiadis; George Theodossiadis
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

View more
  1 in total

1.  [Uveitis in childhood. Small patients--big problems].

Authors:  U Pleyer; R Keitzer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.